Pharmacist-Led Intervention Lowers HbA1c in Type 2 Diabetes
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Sept. 28, 2023 -- A pharmacist-led intervention (UCMyRx) can result in a significant reduction in hemoglobin A1c (HbA1c) concentration among Hispanic patients with type 2 diabetes (T2D), according to a study published online Sept. 28 in JAMA Network Open.
Kimberly Danae Cauley Narain, M.D., Ph.D., M.P.H., from the University of California in Los Angeles, and colleagues examined the association of the UCMyRx intervention with HbA1c and systolic blood pressure (SBP) among 931 patients with T2D, self-reporting Hispanic ethnicity. Participants had one or more visits with a UCMyRx pharmacist (treatment) or two or more visits, two or more years apart, during the study window (March 2, 2013, to Dec. 31, 2018; comparison). The exposure included review of laboratory results, medication reconciliation, and development of personally tailored interventions to address barriers to adherence and increase guideline-concordant care.
The researchers found that having one or more UCMyRx visits was associated with a reduction in HbA1c concentration in adjusted analyses (β = −0.46 percent), but no change was seen in SBP.
"Given the potential of pharmacist-led interventions like UCMyRx to help improve outcomes in T2D while simultaneously supporting primary care physicians, it is important to facilitate their broader uptake," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Fat-Enlarged Axillary Nodes on Mammogram May Indicate Higher CVD Risk
TUESDAY, May 14, 2024 -- Fat-enlarged axillary nodes on screening mammograms can predict the risk for cardiovascular disease (CVD), according to a study presented at the annual...
Metabolic Syndrome, Obesity Independently Linked to Breast Cancer
MONDAY, May 13, 2024 -- Metabolic syndrome (MetS) and obesity have independent and distinct associations with breast cancer subtypes and mortality, according to a study published...
Cardiovascular, Kidney, and Metabolic Syndrome Highly Prevalent in the U.S.
FRIDAY, May 10, 2024 -- Cardiovascular, kidney, and metabolic (CKM) syndrome is highly prevalent in the United States, with more than 90 percent of adults meeting the criteria for...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.